Adenocarcinoma of the uterine cervix: The presence of human papillomavirus and the method of detection

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 10, 2003, Pages 960-965

  Andersson, Sonia ^a   Larson, Barbro ^a   Hjerpe, Anders ^a   Silfverswärd, Claes ^a   Sällström, Jan ^b   Wilander, Erik ^b   Rylander, Eva ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

Adenocarcinoma; Cervical screening; Cervix, human papillomavirus (HPV); Oral contraceptives; Smoking

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADENOCARCINOMA; ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING; SYMPTOMATOLOGY; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; AGE FACTORS; CONTRACEPTIVES, ORAL; DNA, VIRAL; FEMALE; HUMANS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM METASTASIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SMOKING; SWEDEN; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0141426874     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00263.x     Document Type: Article

References (35)

1. Anton-Culver H, Bloss JD, Bringman D, Lee-Feldstein A, DiSaia P, Manetta A. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population based epidemiologic study. Am J Obstet Gynecol 1992; 186: 1507-14.
2. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States. A 24-year population-based study. Gynecol Oncol 2000; 78: 97-105.
3. Herbert A, Singh N, Smith JAE. Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and south-west Hampshire. Cytopathology 2001; 12: 26-36.
4. Miller BE Flax SD, Arheart K, Photopulos G. The presentation of adenocarcinoma of the uterine cervix. Cancer 1993; 72: 1281-5.
5. Munos N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19: 1-5.
6. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
7. Skyldberg BM, Murray E, Lambkin H, Kelehan P, Auer G. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations. Mod Pathol 1999; 12: 675-82.
8. Ferguson AW, Svoboda-Newman SM, Frank TS. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1998; 11: 11-18.
9. Lee MF, Chang MC, Wu CH. Detection of human papillomavirus types in cervical adenocarcinoma by the polymerase chain reaction. Int J Gynaecol Obstet 1998; 63: 265-70.
10. Andersson S, Rylander E, Larsson B, Strand A, Silfversvärd C, Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001; 37: 246-50.
11. Burger MP, Hollema H, Gouw AS, Pieters WJ, Quint WG. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormalities. Br Med J 1993; 152: 776-8.
12. Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev 1995; 4: 415-28.
13. Lacey JV, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Geenberg MD et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinoma. Cancer Epidemiol Biomarkers and Prev 1999; 8: 1079-85.
14. Lungu O, Wright TC, Silverstein S. Typing of human papillomavirus by polymerase chain reaction amplification with L1 consensus primer RFLP analysis. Mol Cell Probes 1992; 6: 145-52.
15. Saiki RK, Chang CA, Levenson CH, Warren TC, Boehm CD, Kazaian HH et al. Diagnosis of sickle cell anemia and β-thalassemia with enzymatically amplified DNA and non-radioactive allele-specific oligonucleotide probes. N Engl Med 1988; 319: 537-41.
16. Zehbe I, Evander M, Edlund K, Rylander E, Wadell G, Wilander E. Non-isotopic detection and typing of human papillomavirus (HPV) by use of polymerase chain reaction and single strand conformation polymorphism (PCR-SSCP). Diagn Mol Pathol 1996; 5: 206-13.
17. Zehbe I, Wilander E. Nonisotopic ELISA-based detection of human papillomavirus-amplified DNA. Mod Pathol 1997; 10: 188-91.
18. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in incidence of cervical cancer. I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998; 75: 536-45.
19. Andersson S, Larson B, Backlund I, Rylander E, Sigurdardóttir S, Sällström J et al. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing. Oncol Rep 2003; 10: 175-9.
20. Milde-Langosch K, Albrecht K, Joran S, Schlechte H, Giessing M, Loning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix and vulva. Int J Cancer 1995; 63: 639-45.
21. Forslund O, Antonsson A, Hansson BG, van den Brule A, Meijer CJLM, Wadell G et al. Population-based type-specific prevalence of high risk human papillomaviruses in middle-aged Swedish women. J Med Virol 2002; 66: 535-41.
22. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O, Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol 1992; 16: 641-9.
23. Barnes W, Delgado G, Kurman RJ, Petrilli ES, Smith DM, Ahmed S et al. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 1988; 29: 267-73.
24. Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA et al. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 2001; 19: 1906-15.
25. Jones CJ Schiffman MH, Kurman R, Jacob P, Benowittz NL. Elevated nicotine levels in cervical lavages from passive smokers. Am J Public Health 1991; 81: 378-9.
26. Prokopczyk B, Cox JE, Hoffman D, Waggoner E. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997; 89: 868-73.
27. Ylitalo N, Sorensen P, Josefsson A, Frisch M, Spare'n P, Ponten J et al. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 1999; 81: 357-65.
28. Brisson J, Morin C, Fortier M, Roy M, Bouchard C, Leclerc J et al. Risk factors for cervical intraepithelial neoplasia: differences between low- and high-grade lesions. Am J Epidemiol 1994; 140: 700-10.
29. World Health Organization. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: result from a multi-national study. WHO collaborative study of neoplasia and steroid contraceptives. Int J Cancer 1993; 55: 228-36.
30. Ursin G, Peters RK, Henderson BE, d'Ablaing G, Monroe KR, Pike MC. Oral contraceptive use and adenocarcinoma of the cervix. Lancet 1994; 344: 1390-4.
31. Munoz N, Bosch FX, Sanjose' S, Vergara A, del Moral A, Munoz MT et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2: 423-31.
32. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64.
33. Hildesheim A, Hadjimichael O, Schwartz PE, Wheeler CM, Barnes W, Lowell DM et al. Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol 1999; 180: 570-7.
34. Krane JF, Granter SR, Trask CE, Hogan CL, Lee KR. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer 2001; 93: 8-15.
35. Ashfag R, Gibbons D, Vela C, Saboorian MH, Fawzi I. ThinPrep Pap Test accuracy for glandular disease. Acta Cytol 1999; 43: 81-5.